AstraZeneca and Daiichi Sankyo’s supplemental Biologics License Application (sBLA) for ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been accepted and granted Priority Review in the US for the ...
Approved dosing regimen reduces the burden for eligible patients, their families, and the broader healthcare system by ...
CarExpert on MSN
2026 Jeep Wrangler review
The Jeep Wrangler has been on sale in Australia for 30 years, but does it still have something to offer in this ever-changing market?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results